An inhaled corticosteroid (ics) that reduces inflammation in the airways.
A long-acting beta2-agonist (laba) that relaxes the muscles around the airways, improving breathing.
A long-acting muscarinic antagonist (lama) that also relaxes airway muscles, providing additional bronchodilation.
Maintenance treatment of chronic obstructive pulmonary disease (COPD) in patients with symptoms.
Maintenance treatment of asthma in patients not adequately controlled by ICS and LABA combination therapies.
This triple combination therapy works synergistically. Ciclesonide reduces airway inflammation, while formoterol and tiotropium both relax the airway muscles, leading to improved airflow and reduced breathlessness. The combined effect provides better symptom control than using the components individually.
Store at room temperature (20-25°C). Protect from moisture and extreme temperatures. Discard the inhaler if the canister is dented or damaged. Consult a pharmacist or physician for proper disposal.
Always follow your doctor's prescribed dosage and administration instructions.
Typically, one inhalation twice daily is used. The precise technique for inhalation should be followed carefully (typically using a spacer device for optimal delivery).
Do not exceed the prescribed dose.
Throat irritation
Cough
Headache
Hoarseness
Oral thrush (candidiasis)
Paradoxical bronchospasm (rare)
No specific interactions with alcohol have been extensively documented, but excessive alcohol consumption may worsen underlying respiratory conditions. Consult your physician.
May cause dizziness or drowsiness in some individuals. Avoid driving or operating machinery if experiencing these side effects.
Consult your doctor before using this medication during pregnancy or breastfeeding. The risks and benefits should be carefully considered.
Safety and efficacy haven't been fully established in children. The use is typically restricted to adults.
Generally well tolerated in patients with mild to moderate kidney impairment. Renal function should be monitored in those with severe impairment.
Generally well tolerated in patients with mild to moderate liver impairment. Hepatic function should be monitored in those with severe impairment.
Please consult your physician or pharmacist for specific references and detailed information on the drug formulation you are prescribed.
Consult your medication's package insert for complete information on the drug formulation.
